Pharmacokinetics of Dihydroartemisinin-Piperaquine in the Treatment of Uncomplicated Malaria in Children in Burkina Faso
Phase 4
Completed
- Conditions
- Uncomplicated Malaria
- First Posted Date
- 2009-02-18
- Last Posted Date
- 2014-01-16
- Lead Sponsor
- University of California, San Francisco
- Registration Number
- NCT00845533
Chromium and Insulin Resistance
Not Applicable
Completed
- Conditions
- Insulin Resistance
- Interventions
- Dietary Supplement: ChromiumDietary Supplement: placebo
- First Posted Date
- 2009-02-18
- Last Posted Date
- 2012-08-31
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 75
- Registration Number
- NCT00846248
- Locations
- 🇺🇸
UCSF, San Francisco, California, United States
Newborn Screening for Severe Combined Immunodeficiency (SCID) in a High-Risk Population
Completed
- Conditions
- Severe Combined ImmunodeficiencyT Cell Lymphocytopenia
- First Posted Date
- 2009-02-18
- Last Posted Date
- 2012-07-16
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 1800
- Registration Number
- NCT00845416
- Locations
- 🇺🇸
Tuba City Hospital, Tuba City, Arizona, United States
🇺🇸Chinle Hospital, Chinle, Arizona, United States
Alpha Lipoic Acid and Insulin Resistance
Not Applicable
Completed
- Conditions
- Insulin Resistance
- Interventions
- Dietary Supplement: Alpha Lipoic Acid
- First Posted Date
- 2009-02-18
- Last Posted Date
- 2013-06-20
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 68
- Registration Number
- NCT00845156
- Locations
- 🇺🇸
University of California at San Francisco, San Francisco, California, United States
Patient Expectations After Implantable-cardioverter Defibrillator (ICD) Implantation
Completed
- Conditions
- Defibrillators, Implantable
- First Posted Date
- 2009-02-18
- Last Posted Date
- 2022-03-21
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 100
- Registration Number
- NCT00845390
- Locations
- 🇺🇸
UCSF Arrhythmia and Device Clinic, San Francisco, California, United States
Treatment of Acute Hepatitis C Virus in HIV Co-Infection
Phase 4
Completed
- Conditions
- HIV InfectionsHuman Immunodeficiency VirusHepatitis C
- Interventions
- Drug: Pegylated interferon alfa-2a + Ribavirin
- First Posted Date
- 2009-02-18
- Last Posted Date
- 2020-05-18
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 21
- Registration Number
- NCT00845676
- Locations
- 🇺🇸
San Francisco General Hospital/UCSF, San Francisco, California, United States
Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab Therapy
Not Applicable
Completed
- Conditions
- Endothelial FunctionRheumatoid ArthritisInflammation
- Interventions
- First Posted Date
- 2009-02-16
- Last Posted Date
- 2015-06-26
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 20
- Registration Number
- NCT00844714
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Electrocardiographic Autonomic Function Measures in Mechanically Ventilated Patients
Withdrawn
- Conditions
- Disorders of the Autonomic Nervous SystemCardiovascular AbnormalitiesRespiratory Disorders
- First Posted Date
- 2009-02-16
- Last Posted Date
- 2012-03-28
- Lead Sponsor
- University of California, San Francisco
- Registration Number
- NCT00844935
- Locations
- 🇺🇸
University of California, San Francisco Medical Center, San Francisco, California, United States
Effect of Maraviroc on Endothelial Function in HIV-Infected Patients
Phase 3
Completed
- Conditions
- HIV InfectionCardiovascular DiseaseHIV InfectionsInflammation
- Interventions
- Drug: placebo
- First Posted Date
- 2009-02-16
- Last Posted Date
- 2014-07-24
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 52
- Registration Number
- NCT00844519
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Epidemiology and Pathogenesis of HIV-Associated Pulmonary Hypertension
Completed
- Conditions
- HIV InfectionEndothelial FunctionHIV InfectionsPulmonary Hypertension
- First Posted Date
- 2009-02-16
- Last Posted Date
- 2021-11-10
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 365
- Registration Number
- NCT00845013
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
© Copyright 2025. All Rights Reserved by MedPath